Clinical Trial Update: MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder [Phase 3]

View source ↗

Summary

Phase 3 trial update for MRX-7EAT etodolac-lidocaine topical patch in acute tendonitis and bursitis of the shoulder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bursitis of the Shoulder
• Tendonitis

Drugs mentioned

• MRX-7EAT etodolac-lidocaine topical patch (etodolac-lidocaine topical patch)

Snippet

Sponsor: MEDRx USA, Inc. | Conditions: Acute Tendonitis, Bursitis | Phase 3 | Status: COMPLETED